1. Home
  2. BBDC vs VALN Comparison

BBDC vs VALN Comparison

Compare BBDC & VALN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Barings BDC Inc.

BBDC

Barings BDC Inc.

HOLD

Current Price

$9.07

Market Cap

946.4M

Sector

Finance

ML Signal

HOLD

Logo Valneva SE

VALN

Valneva SE

N/A

Current Price

$8.71

Market Cap

820.0M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
BBDC
VALN
Founded
2006
2012
Country
United States
France
Employees
N/A
N/A
Industry
Diversified Financial Services
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
946.4M
820.0M
IPO Year
2007
2021

Fundamental Metrics

Financial Performance
Metric
BBDC
VALN
Price
$9.07
$8.71
Analyst Decision
Buy
Strong Buy
Analyst Count
3
4
Target Price
$9.67
$15.75
AVG Volume (30 Days)
726.9K
19.7K
Earning Date
11-06-2025
11-20-2025
Dividend Yield
11.52%
N/A
EPS Growth
N/A
N/A
EPS
0.96
N/A
Revenue
$281,866,000.00
$211,089,992.00
Revenue This Year
N/A
$5.08
Revenue Next Year
N/A
$12.53
P/E Ratio
$9.37
N/A
Revenue Growth
N/A
13.48
52 Week Low
$7.66
$3.62
52 Week High
$10.85
$12.25

Technical Indicators

Market Signals
Indicator
BBDC
VALN
Relative Strength Index (RSI) 57.29 44.05
Support Level $8.62 $8.62
Resistance Level $9.09 $9.10
Average True Range (ATR) 0.13 0.29
MACD 0.01 0.02
Stochastic Oscillator 80.73 12.25

Price Performance

Historical Comparison
BBDC
VALN

About BBDC Barings BDC Inc.

Barings BDC Inc operates as a closed-end, non-diversified investment company and has elected to be treated as a business development company. The company's investment objective is to generate current income by investing directly in privately held middle-market companies to help these companies fund acquisitions, growth, or refinancing. Barings employs fundamental credit analysis and targets investments in businesses with low levels of cyclicality and operating risk relative to other businesses in this market segment. The holding size of each position will generally be dependent upon a number of factors including total facility size, pricing and structure, and the number of other lenders in the facility.

About VALN Valneva SE

Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.

Share on Social Networks: